HaTay Pharmaceutical JSC

HaTay Pharmaceutical JSC CROIC

The Cash Return on Invested Capital (CROIC) of HaTay Pharmaceutical JSC (DHT.VN) as of Nov 2, 2026 is -7.68 %. In the previous year, Cash Return on Invested Capital (CROIC) was -6.21 % — a change of 23.71% (lower).

CROIC

-7.68 %

YoY

23.71%

Last updated:

Cash Return on Invested Capital (CROIC) of HaTay Pharmaceutical JSC is 2024 -7.68 % . Cash Return on Invested Capital (CROIC) of HaTay Pharmaceutical JSC was 2023 -6.21 % . It decreases by 23.71% lower compared to the previous year.

The HaTay Pharmaceutical JSC CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2017
-3.43 VND
Jan 1, 2018
15.96 VND
Jan 1, 2019
14.83 VND
Jan 1, 2020
1.07 VND
Jan 1, 2021
-8.22 VND
Jan 1, 2022
-25.76 VND
Jan 1, 2023
-6.21 VND
Jan 1, 2024
-7.68 VND
The HaTay Pharmaceutical JSC CROIC history
YEARCROICYoY
-7.68 %+23.71%
-6.21 %-75.90%
-25.76 %+213.28%
-8.22 %-868.45%
1.07 %-92.78%
14.83 %-7.12%
15.96 %-565.00%
-3.43 %-133.90%
10.13 %-211.42%
-9.09 %+444.36%
-1.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

HaTay Pharmaceutical JSC Stock analysis

What does HaTay Pharmaceutical JSC do? Ha Tay Pharmaceutical JSC generates revenue through the manufacturing, import, and export of pharmaceuticals, cosmetics, and medical equipment. The company sells its products via wholesale and retail channels, targeting healthcare providers, pharmacies, and consumers. It also engages in the production and trading of cosmetic products, supplemental food, and laboratory chemicals, alongside medical equipment and supplies. The firm completed the acquisition of a 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company in 2013, expanding its market presence in pharmaceuticals and medical equipment. The company operates in the pharmaceutical sector, serving healthcare institutions, retail pharmacies, and end consumers. Its revenue streams include the sale of drugs, cosmetics, medical equipment, and related supplies. Additional income comes from supermarket operations, real estate leasing, and vocational training services, though these are secondary to its core pharmaceutical business. Ha Tay Pharmaceutical JSC's primary customers are healthcare providers, pharmacies, and consumers purchasing pharmaceuticals, cosmetics, and medical equipment. The firm's product portfolio spans drugs, vaccines, cosmetic products, supplemental food, and laboratory chemicals, with a focus on manufacturing and trading. The acquisition of the 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company has strengthened its position in the medical equipment market. HaTay Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about HaTay Pharmaceutical JSC stock

Cash Return on Invested Capital (CROIC) of HaTay Pharmaceutical JSC is -7.68 % in 2024.

Cash Return on Invested Capital (CROIC) of HaTay Pharmaceutical JSC changed from -6.21 % to -7.68 %, representing a 23.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) HaTay Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s HaTay Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — HaTay Pharmaceutical JSC

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — HaTay Pharmaceutical JSC